[
    [
        {
            "time": "2020-03-18",
            "original_text": "复星医药(02196.HK)：控股股东增持计划已过半 累计增持0.28%股份",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股股东",
                    "增持",
                    "股份"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)：控股股东增持计划已过半 累计增持0.28%股份",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-03-30",
            "original_text": "复星医药(02196.HK)3月30日董事会考虑及通过全年业绩",
            "features": {
                "keywords": [
                    "复星医药",
                    "董事会",
                    "全年业绩"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)3月30日董事会考虑及通过全年业绩",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-03-18",
            "original_text": "港股异动︱与BioNTech强强联合共抗COVID-19 复星医药(02196)续涨逾8%",
            "features": {
                "keywords": [
                    "复星医药",
                    "BioNTech",
                    "COVID-19",
                    "联合",
                    "上涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱与BioNTech强强联合共抗COVID-19 复星医药(02196)续涨逾8%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-03-18",
            "original_text": "法匹拉韦量产投入临床 医药股普涨四环医药涨近9%",
            "features": {
                "keywords": [
                    "法匹拉韦",
                    "量产",
                    "临床",
                    "医药股",
                    "普涨"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "法匹拉韦量产投入临床 医药股普涨四环医药涨近9%",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-03-18",
            "original_text": "全国首款重组新冠疫苗背后的康希诺生物：已研发15种疫苗产品 正在冲击“A+H”",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "康希诺生物",
                    "研发",
                    "A+H"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "全国首款重组新冠疫苗背后的康希诺生物：已研发15种疫苗产品 正在冲击“A+H”",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-03-18",
            "original_text": "美股新冠疫苗龙头暴涨66%! A股影子股起飞，疫苗距离上市还有多远",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "美股",
                    "龙头",
                    "暴涨",
                    "A股",
                    "影子股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "美股新冠疫苗龙头暴涨66%! A股影子股起飞，疫苗距离上市还有多远",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]